A new research paper noting the similarities with Covid-19 and HIV, which is also indicative of why Biotron has confidence with BIT225 with HIV and variations of BIT225/037 compounds that are being tested for Covid-19.
"This new research findings has massive implications and changes everything on how the disease should be treated to even out the effects that the virus has on the long term health implications of "recovered" Covid-19 patients."
Although all the talk has been about BIT and the potential with Covid-19, the companies core focus is BIT225 and HIV, and IMO I would think that we will receive good news on the BIT225 prior to that of Covid-19 (which may only be in a couple of months)
Either way it's going to be an interesting couple of months (maybe weeks)
BIT Price at posting:
8.9¢ Sentiment: Buy Disclosure: Held
